William Goolsbee
Director/Board Member bij HELIX BIOMEDIX, INC.
Profiel
William Alden Goolsbee was the founder of Horizon Medical, Inc. (founded in 1987) where he held the title of Chairman & Chief Executive Officer in 2002.
He is currently the Chairman & Chief Executive Officer at BMG Hematology LLC and an Independent Director at Helix BioMedix, Inc. He previously served as Chairman of Immunotherapy Corp.
from 1995 to 1998, Chairman of BMG Pharma LLC from 2006 to 2011, Chairman of Metrodora Therapeutics, Inc., Independent Director at Sarepta Therapeutics, Inc. from 2014 to 2016, and Independent Non-Executive Director at Percheron Therapeutics Ltd.
from 2015 to 2021.
Mr. Goolsbee obtained his undergraduate degree from the University of California, Santa Barbara.
Actieve functies van William Goolsbee
| Bedrijven | Functie | Begin |
|---|---|---|
| HELIX BIOMEDIX, INC. | Director/Board Member | 01-01-2019 |
| BMG Hematology LLC | Chief Executive Officer | - |
Eerdere bekende functies van William Goolsbee
| Bedrijven | Functie | Einde |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Director/Board Member | 15-12-2021 |
| SAREPTA THERAPEUTICS, INC. | Chairman | 30-07-2014 |
| Metrodora Therapeutics, Inc. | Chairman | 01-01-2015 |
| BMG Pharma LLC | Chairman | 01-01-2011 |
| Horizon Medical, Inc. | Chief Executive Officer | 01-01-2002 |
Opleiding van William Goolsbee
| University of California, Santa Barbara | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| Horizon Medical, Inc. | Health Technology |
Immunotherapy Corp.
 Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The private company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Health Technology |
| BMG Pharma LLC | |
| BMG Hematology LLC | |
| Metrodora Therapeutics, Inc. |
